MetaStat Stock

MetaStat Net Income

The Net Income of MetaStat (MTST) as of Aug 22, 2026 is -3.31 M USD. In the previous year, Net Income was -6.22 M USD — a change of -46.76% (higher).

Net Income

-3.31 MUSD

YoY

-46.76%

Last updated:

In 2026, MetaStat's profit amounted to -3.31 M USD, a -46.76% increase from the -6.22 M USD profit recorded in the previous year.

The MetaStat Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2011
-100,000.00 USD
Jan 1, 2012
-2.43 M USD
Jan 1, 2013
-2.52 M USD
Jan 1, 2014
-5.37 M USD
Jan 1, 2015
-8.24 M USD
Jan 1, 2016
-5.99 M USD
Jan 1, 2017
-6.22 M USD
Jan 1, 2018
-3.31 M USD
The MetaStat Net Income history
YEARNet IncomeYoY
-3.31 MUSD-46.76%
-6.22 MUSD+3.82%
-5.99 MUSD-27.30%
-8.24 MUSD+53.54%
-5.37 MUSD+112.85%
-2.52 MUSD+3.73%
-2.43 MUSD+2,330.00%
-100,000.00USD+11.11%
-90,000.00USD-76.32%
-380,000.00USD+216.67%
-120,000.00USD
Access this data via the Eulerpool API

MetaStat Revenue

MetaStat Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2011
0.00 USD
-100,000.00 USD
-100,000.00 USD
Jan 1, 2012
0.00 USD
-2.28 M USD
-2.43 M USD
Jan 1, 2013
0.00 USD
-2.52 M USD
-2.52 M USD
Jan 1, 2014
0.00 USD
-4.35 M USD
-5.37 M USD
Jan 1, 2015
0.00 USD
-4.79 M USD
-8.24 M USD
Jan 1, 2016
0.00 USD
-4.78 M USD
-5.99 M USD
Jan 1, 2017
0.00 USD
-3.35 M USD
-6.22 M USD
Jan 1, 2018
23,300.00 USD
-3.55 M USD
-3.31 M USD

MetaStat Margins

MetaStat stock margins

The MetaStat margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MetaStat. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MetaStat.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2011
0.00 %
- %
- %
Jan 1, 2012
0.00 %
- %
- %
Jan 1, 2013
0.00 %
- %
- %
Jan 1, 2014
0.00 %
- %
- %
Jan 1, 2015
0.00 %
- %
- %
Jan 1, 2016
0.00 %
- %
- %
Jan 1, 2017
0.00 %
- %
- %
Jan 1, 2018
0.00 %
-15,238.20 %
-14,206.44 %

MetaStat Stock analysis

What does MetaStat do? MetaStat Inc. is a biopharmaceutical company focused on the development of therapeutics for cancer. It was founded in Massachusetts in 2000 and has been listed on NASDAQ since 2013. The company's main focus is on blocking the protein Meta-1, which is associated with the formation of metastases, in order to stop the spread of cancer. MetaStat's business model is based on marketing medications and diagnostics. They work closely with researchers and clinicians to develop new products and conduct clinical trials. The company operates in two divisions: therapeutics and diagnostics. The therapeutics division focuses on developing medications targeting the Meta-1 protein, while the diagnostics division develops tests to detect Meta-1 protein in patients' blood to identify metastases early on. MetaStat's main product is the MetaSite Breast Test, a diagnostic test for breast cancer that uses proprietary technologies to detect the presence of Meta-1 in tumor tissue. The company also has several therapeutics in the pipeline, with MSC-1, a small molecule that blocks the function of Meta-1 and inhibits the formation of metastases, being the leading product. MetaStat has established partnerships with several research institutions and companies to advance its research and development. In summary, MetaStat is a biopharmaceutical company specializing in the development of therapeutics and diagnostics for cancer. They have developed innovative technology to detect the presence of Meta-1 in tumor tissue and inhibit the formation of metastases. Their main product is the MetaSite Breast Test, which determines the risk of metastases in breast cancer patients. The company has established partnerships with research institutions and companies to advance its research and development and further develop its pipeline of therapeutics. MetaStat is one of the most popular companies on Eulerpool.

Net Income Details

Understanding MetaStat's Profit Margins

The profit margins of MetaStat represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of MetaStat's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating MetaStat's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

MetaStat's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When MetaStat’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about MetaStat stock

Net Income of MetaStat is -3.31 M USD in 2026.

Net Income of MetaStat changed from -6.22 M USD to -3.31 M USD, representing a -46.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income MetaStat since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's MetaStat historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

Income Statement — MetaStat

All Key Metrics — MetaStat